Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2013 April;61(2) > Minerva Cardioangiologica 2013 April;61(2):243-54

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

REVIEWS  


Minerva Cardioangiologica 2013 April;61(2):243-54

language: English

From the abluminal biodegradable polymer stent to the polymer free stent. Clinical evidence

Navarese E. P. 1, Castriota F. 1, Sangiorgi G. M. 2, Cremonesi A. 1

1 Interventional Cardio-Angiology Unit, GVM Care and Research, Cotignola, Ravenna, Italy;
2 Department of Cardiology, Policlinico Tor Vergata, Rome, Italy


PDF  


The implementation of methods of the coronary angioplasty was one of the most important achievement in the field of treatment of coronary artery disease. Abluminal biodegradable polymer stents (BDS) and polymer free stent are the newest and the most promising research concerning coronary stent technology. In this article we discuss the perceived need for BDS-polymer free stents, the current clinical evidence, limits and future perspectives.

top of page

Publication History

Cite this article as

Corresponding author e-mail

eliano.navarese@alice.it